Synthetic viruslike particles for targeted gene delivery to alphavbeta3 integrin-presenting endothelial cells

Guy Zuber1, Monique Dontenwill, Jean-Paul Behr

  • 1Laboratoire de Conception et Application de Molecules Bioactives, CNRS-Universite de Strasbourg UMR7199, Faculte de Pharmacie, 74, route du rhin, 67400 Illkirch, France. zuber@bioorga.u-strasbg.fr

Molecular Pharmaceutics
|August 19, 2009
PubMed

Related Concept Videos